These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 17348011

  • 1. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis.
    Brown DA, Sawchenko PE.
    J Comp Neurol; 2007 May 10; 502(2):236-60. PubMed ID: 17348011
    [Abstract] [Full Text] [Related]

  • 2. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ, Truong JJ, Kerr BJ.
    Pain; 2009 Jan 10; 141(1-2):156-64. PubMed ID: 19084337
    [Abstract] [Full Text] [Related]

  • 3. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R.
    J Autoimmun; 2011 Nov 10; 37(3):228-41. PubMed ID: 21752599
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis.
    Jones MV, Nguyen TT, Deboy CA, Griffin JW, Whartenby KA, Kerr DA, Calabresi PA.
    J Neuroimmunol; 2008 Aug 13; 199(1-2):83-93. PubMed ID: 18582952
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS, Stormanns ER, Bader J, Arnhold S, Addicks K, Kuerten S.
    Clin Immunol; 2013 Oct 13; 149(1):32-45. PubMed ID: 23899992
    [Abstract] [Full Text] [Related]

  • 8. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
    Pifarré P, Gutierrez-Mecinas M, Prado J, Usero L, Roura-Mir C, Giralt M, Hidalgo J, García A.
    Exp Neurol; 2014 Jan 13; 251():58-71. PubMed ID: 24211383
    [Abstract] [Full Text] [Related]

  • 9. Sildenafil (Viagra) ameliorates clinical symptoms and neuropathology in a mouse model of multiple sclerosis.
    Pifarre P, Prado J, Baltrons MA, Giralt M, Gabarro P, Feinstein DL, Hidalgo J, Garcia A.
    Acta Neuropathol; 2011 Apr 13; 121(4):499-508. PubMed ID: 21234581
    [Abstract] [Full Text] [Related]

  • 10. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.
    Wang D, Ayers MM, Catmull DV, Hazelwood LJ, Bernard CC, Orian JM.
    Glia; 2005 Aug 15; 51(3):235-40. PubMed ID: 15812814
    [Abstract] [Full Text] [Related]

  • 11. Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis.
    Einstein O, Grigoriadis N, Mizrachi-Kol R, Reinhartz E, Polyzoidou E, Lavon I, Milonas I, Karussis D, Abramsky O, Ben-Hur T.
    Exp Neurol; 2006 Apr 15; 198(2):275-84. PubMed ID: 16472805
    [Abstract] [Full Text] [Related]

  • 12. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
    Villares R, Cadenas V, Lozano M, Almonacid L, Zaballos A, Martínez-A C, Varona R.
    Eur J Immunol; 2009 Jun 15; 39(6):1671-81. PubMed ID: 19499521
    [Abstract] [Full Text] [Related]

  • 13. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ, Tenorio G, Sauve Y, Kerr BJ.
    Exp Neurol; 2013 Mar 15; 241():113-21. PubMed ID: 23291347
    [Abstract] [Full Text] [Related]

  • 14. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
    Gentile A, Musella A, Bullitta S, Fresegna D, De Vito F, Fantozzi R, Piras E, Gargano F, Borsellino G, Battistini L, Schubart A, Mandolesi G, Centonze D.
    J Neuroinflammation; 2016 Aug 26; 13(1):207. PubMed ID: 27566665
    [Abstract] [Full Text] [Related]

  • 15. Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis.
    Pryor WM, Freeman KG, Larson RD, Edwards GL, White LJ.
    J Neurosci Res; 2015 May 26; 93(5):697-706. PubMed ID: 25510644
    [Abstract] [Full Text] [Related]

  • 16. Neurodegeneration and inflammation in hippocampus in experimental autoimmune encephalomyelitis induced in rats by one--time administration of encephalitogenic T cells.
    Kurkowska-Jastrzębska I, Swiątkiewicz M, Zaremba M, Cudna A, Piechal A, Pyrzanowska J, Widy-Tyszkiewicz E, Członkowska A.
    Neuroscience; 2013 Sep 17; 248():690-8. PubMed ID: 23806721
    [Abstract] [Full Text] [Related]

  • 17. Expression of citrullinated proteins in murine experimental autoimmune encephalomyelitis.
    Nicholas AP, Sambandam T, Echols JD, Barnum SR.
    J Comp Neurol; 2005 Jun 06; 486(3):254-66. PubMed ID: 15844173
    [Abstract] [Full Text] [Related]

  • 18. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vogt J, Paul F, Aktas O, Müller-Wielsch K, Dörr J, Dörr S, Bharathi BS, Glumm R, Schmitz C, Steinbusch H, Raine CS, Tsokos M, Nitsch R, Zipp F.
    Ann Neurol; 2009 Sep 06; 66(3):310-22. PubMed ID: 19798635
    [Abstract] [Full Text] [Related]

  • 19. Neurodegeneration in autoimmune CNS inflammation.
    Herz J, Zipp F, Siffrin V.
    Exp Neurol; 2010 Sep 06; 225(1):9-17. PubMed ID: 19961850
    [Abstract] [Full Text] [Related]

  • 20. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA, Welsh ME, Carter DE, Karlik SJ.
    J Neuroimmunol; 2009 Apr 30; 209(1-2):6-15. PubMed ID: 19233483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.